Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 31 results.
User Information
Export Records
  1. 1.   Identification of a Structural Element in HIV-1 Gag Required for Virus Particle Assembly and Maturation
  2. Novikova, Mariia; Adams, Lucas J.; Fontana, Juan; Gres, Anna T.; Balasubramaniam, Muthukumar; Winkler, Dennis C.; Kudchodkar, Sagar B.; Soheilian,Ferri; Sarafianos, Stefan G.; Steven, Alasdair C.; Freed,Eric
  3. MBIO. 2018, SEP-OCT; 9(5):
  1. 2.   Virus maturation as a new HIV-1 therapeutic target
  2. Adamson, C. S.; Salzwedel, K.; Freed, E. O.
  3. Expert opinion on therapeutic targets. 2009, Aug; 13(8): 895-908.
  1. 3.   Real-time PCR analysis of HIV-1 replication post-entry events
  2. Mbisa, J. L.; Delviks-Frankenberry, K. A.; Thomas, J. A.; Gorelick, R. J.; Pathak, V. K.
  3. Methods in molecular biology (Clifton, N.J.). 2009 485: 55-72.
  1. 4.   HIV-1 RNA dimerization: It takes two to tango
  2. Moore, M. D.; Hu, W. S.
  3. Aids Reviews. 2009 11(2): 91-102.
  1. 5.   Lytic Granule Loading of CD8(+) T Cells Is Required for HIV-Infected Cell Elimination Associated with Immune Control
  2. Migueles, S. A.; Osborne, C. M.; Royce, C.; Compton, A. A.; Joshi, R. P.; Weeks, K. A.; Rood, J. E.; Berkley, A. M.; Sacha, J. B.; Cogliano-Shutta, N. A.; Lloyd, M.; Roby, G.; Kwan, R.; McLaughlin, M.; Stallings, S.; Rehm, C.; O'Shea, M. A.; Mican, J.
  3. Immunity. 2008 29(6): 1009-1021.
  1. 6.   The high-frequency major histocompatibility complex class I allele Mamu-B*17 is associated with control of simian immunodeficiency virus SIVmac239 replication
  2. Yant, L. J.; Friedrich, T. C.; Johnson, R. C.; May, G. E.; Maness, N. J.; Enz, A. M.; Lifson, J. D.; O'Connor, D. H.; Carrington, M.; Watkins, D. I.
  3. Journal of Virology. 2006, MAY; 80(10): 5074-5077.
  1. 7.   HIV-1 gp120 induces NFAT nuclear translocation in resting CD4+T-cells
  2. Cicala, C.; Arthos, J.; Censoplano, N.; Cruz, C.; Chung, E.; Martinelli, E.; Lempicki, R. A.; Natarajan, V.; VanRyk, D.; Daucher, M.; Fauci, A. S.
  3. Virology. 2006, FEB 5; 345(1): 105-114.
  1. 8.   Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes
  2. Frahm, N.; Kiepiela, P.; Adams, S.; Linde, C. H.; Hewitt, H. S.; Sango, K.; Feeney, M. E.; Addo, M. M.; Lichterfeld, M.; Lahaie, M. P.; Pae, E.; Wurcel, A. G.; Roach, T.; St John, M. A.; Altfeld, M.; Marincola, F. M.; Moore, C.; Mallal, S.; Carrington, M.; Heckerman, D.; Allen, T. M.; Mullins, J. I.; Korber, B. T.; Goulder, P. J. R.; Walker, B. D.; Br, er
  3. Nature Immunology. 2006, FEB; 7(2): 173-178.
  1. 9.   Complex interactions of HIV-1 nucleocapsid protein with oligonucleotides
  2. Fisher, R. J.; Fivash, M. J.; Stephen, A. G.; Hagan, N. A.; Shenoy, S. R.; Medaglia, M. V.; Smith, L. R.; Worthy, K. M.; Simpson, J. T.; Shoemaker, R.; McNitt, K. L.; Johnson, D. G.; Hixson, C. V.; Gorelick, R. J.; Fabris, D.; Henderson, L. E.; Rein, A.
  3. Nucleic Acids Research. 2006 34(2): 472-484.
  1. 10.   Identification of a major restriction in HIV-1 intersubtype recombination
  2. Chin, M. P. S.; Rhodes, T. D.; Chen, J. B.; Fu, W.; Hu, W. S.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2005, JUN 21; 102(25): 9002-9007.
  1. 11.   Cooperative effect of Gag proteins p12 and capsid during early events of murine leukemia virus replication
  2. Lee, S. K.; Nagashima, K.; Hu, W. S.
  3. Journal of Virology. 2005 79(7): 4159-4169.
  1. 12.   Effects of mutations in the G tract of the human immunodeficiency virus type 1 polypurine tract on virus replication and RNase H cleavage
  2. Julias, J. G.; McWilliams, M. J.; Sarafianos, S. G.; Alvord, W. G.; Arnold, E.; Hughes, S. H.
  3. Journal of Virology. 2004, DEC; 78(23): 13315-13324.
  1. 13.   Insufficient production and tissue delivery of CD4(+) memory T cells in rapidly progressive simian immunodeficiency virus infection
  2. Picker, L. J.; Hagen, S. I.; Lum, R.; Reed-Inderbitzin, E. F.; Daly, L. M.; Sylwester, A. W.; Walker, J. M.; Siess, D. C.; Piatak, M.; Wang, C. X.; Allison, D. B.; Maino, V. C.; Lifson, J. D.; Kodama, T.; Axthelm, M. K.
  3. Journal of Experimental Medicine. 2004, NOV 15; 200(10): 1299-1314.
  1. 14.   Eradication of HIV in infected patients: Some potential approaches
  2. Yang, Q. E.
  3. Medical Science Monitor. 2004, JUL; 10(7): RA155-RA165.
  1. 15.   Genetic control of myreloproliferation in BXH-2 mice
  2. Turcotte, K.; Gauthier, S.; Mitsos, L. M.; Shustik, C.; Copeland, N. G.; Jenkins, N. A.; Fournet, J. C.; Jolicoeur, P.; Gros, P.
  3. Blood. 2004 103(6): 2343-2350.
  1. 16.   Human immunodeficiency virus type 1 nucleocapsid protein can prevent self-priming of minus-strand strong stop DNA by promoting the annealing of short oligonucleotides to hairpin sequences
  2. Driscoll, M. D.; Hughes, S. H.
  3. Journal of Virology. 2000 74(19): 8785-92.
  1. 17.   HIV-1 induced in the setting of IL-2 therapy is transient and not derived from PBMC proviral reservoirs
  2. Imamichi, H.; Zhang, Y. M.; Kovacs, J.; Dewar, R.; Metcalf, J.; Vogel, S.; Salzman, N.; Lane, H. C.
  3. Conference on Retroviruses and Opportunistic Infections. 1999, 135 (abstract no. 358).
  1. 18.   Pathogenesis: disease mechanisms in humans and animal models the human genes that limit AIDS
  2. O'Brien, S.; Dean, M.; Carrington, M.; Winkler, C.; Smith, M.; Nelson, G.; Stephens, J. C.
  3. Conference on Retroviruses and Opportunistic Infections. 1999, 214 (abstract no. S14).
  1. 19.   Conformationally-intact inactivated SIV virions as an antigen to monitor specific proliferative responses to SIV
  2. Rossio, J.; Schneider, D.; Coalter, V.; Kiser, R.; Desrosiers, R.; Arthur, L.; Lifson, J.
  3. Conference on Retroviruses and Opportunistic Infections. 1999, 172 (abstract no. 558).
  1. 20.   A distamycin analog selectively blocks chemokine receptor function and HIV-1 fusion
  2. Turpin, J. A.; Rice, W. G.; Oppenheim, J. J.; Hollingshead, M. G.; Covey, J. M.; Howard, O. M.
  3. HIV Pathogenesis and Treatment Conference. 1998, 57 (abstract no. 2042).
  1. 21.   In vitro and in vivo activity of anti-retroviral compounds attacking NC zinc fingers
  2. Henderson, L. E.; Chertova, E.; Ott, D.; Hewes, S. M.; Cases-Finet, J. R.; Kane, B.; Johnson, D. G.; Sowder, I. R.; Rossio, J.; Lifson, J.; Arthur, L. O.
  3. Conference on Retroviruses and Opportunistic Infections. 1998, 80 (abstract no. 7).
  1. 22.   Replication of the Rev-independent nef(-) SIV in juvenile macaques
  2. Felber, B. K.; von Gegerfelt, A. S.; Liska, V.; Ruprecht, R. M.
  3. Conference on Retroviruses and Opportunistic Infections. 1998, 131 (abstract no. 279).
  1. 23.   Identification of potential HIV-1 integrase (IN) inhibitors by co-localization of antiviral activity with integrase mediated events in the retroviral replication cycle
  2. Rice, W. G.; Schaeffer, C. A.; Bu, M.; Williamson, K.; Turpin, J. A.
  3. HIV Pathogenesis and Treatment Conference. 1998, 55 (abstract no. 2036).
  1. 24.   HIV replication persists in patients receiving HAART despite undetectable plasma virus
  2. Nata Rajan, V. N.; Chun, T. W.; O'Neill, D. P.; Metcalf, J. A.; Mican, J.; Engel, D.; Fauci, A. S.; Lane, H. C.; Kovacs, J. A.
  3. International Conference on AIDS. 1998, 12 341-2.
  1. 25.   New types of anti-HIV agents identified by the NCI drug discovery program. Eleventh International Conference on Antiviral Research
  2. Rice, W. G.; Turpin, J. A.; Huang, M.; Howard, O. M.; Michejda, C. J.; Bader, J. P.
  3. Antiviral Research. 1998 37(3): A58 (abstract no. 64).
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel